Pinsent Masons advises Intelligent Energy on IPO

14 Jul 2014 | 01:20 pm |

International law firm Pinsent Masons has advised Intelligent Energy on its initial public offering (IPO) raising a total of £55 million.

The deal, thought to be London's biggest pure technology flotation in five years, values the green power company at $1.1bn (£639 million). Intelligent Energy intends to use the funds raised to pursue international expansion plans.

Corporate partners Rob Hutchings, Louise Wolfson and senior associate James Broadhurst led a Pinsent Masons team advising on the transaction.

Commenting on the deal, Rob Hutchings, said:
"The flotation represents a significant milestone for Intelligent Energy. It provides the funding needed to embark on ambitious growth plans as the company enters the next stage of its development.

"We are delighted to have assisted our client on a deal which is critical for their business and also demonstrates an appetite for innovative clean tech investments in the UK market."

Intelligent Energy is a longstanding client for Pinsent Masons. In 2013, the firm advised the company on its £30 million convertible loan note issuance and earlier this year advised on its issue of warrants.

Chief financial officer at Intelligent Energy, John Maguire, said: "We very much enjoyed working with the Pinsent Masons team, who in turn worked closely with ours to help us reach this important milestone in Intelligent Energy's development."

Latest press releases

Show me all press releases

Pinsent Masons advises Simpson Malt Limited on £90m refinancing deal

Multinational law firm Pinsent Masons has advised Simpson Malt Limited on a £90m asset based lending (ABL) facility with PNC Business Credit.

Pinsent Masons wins 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards

Pinsent Masons was named 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards, which was held virtually on 27 November 2020.

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts